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Abbreviations {#feb212180-sec-0001}
=============

**CTLH**, C‐terminal to LisH

**GID** glucose‐induced degradation‐deficient

**LisH**, lis homology

**MO**, morpholino oligonucleotides

 {#feb212180-sec-0002}

Wnt signaling plays multiple important roles in disease and embryogenesis [1](#feb212180-bib-0001){ref-type="ref"}, [2](#feb212180-bib-0002){ref-type="ref"}. β‐Catenin is a key component in the canonical Wnt signaling pathway, and its stability and localization influence Wnt activity. Cytoplasmic levels of β‐catenin are kept low, in the 'Wnt off' state, by a degradation complex that includes Axin, APC, and GSK‐3β. CK1α initially phosphorylates β‐catenin at serine 45 (S45) of the N‐terminal region, and GSK‐3β subsequently phosphorylates β‐catenin at threonine 41 (T41), serine 37 (S37), and serine 33 (S33) [3](#feb212180-bib-0003){ref-type="ref"}. The phosphorylated β‐catenin is recognized and ubiquitinated at lysine 19 (K19) and lysine 49 (K49) by the ubiquitin E3 ligase, β‐TrCP. The ubiquitinated β‐catenin is degraded by the proteasome [4](#feb212180-bib-0004){ref-type="ref"}. In the 'Wnt on' state, the Wnt ligand binds to Frizzled receptor and the LRP complex at the cell surface, which leads to the membrane recruitment and activation of scaffold protein, Dishevelled. Activated Dishevelled inactivates the APC/Axin/GSK‐3 complex in the cytoplasm, thus reducing degradation of β‐catenin. The stabilized β‐catenin translocates to the nucleus and associates with TCF/LEF transcription factors to activate Wnt target genes [5](#feb212180-bib-0005){ref-type="ref"}.

Axin1 is a scaffold protein including a multidomain that has many functions in biological signaling pathways. Axin1 contains: a regulation of G‐protein signaling (RGS) domain, which binds to APC, at the N‐terminus; a dishevelled and axin (DIX) domain and a protein phosphatase 2 (PP2A)‐binding domain at the C‐terminus; and binding domains of GSK‐3β and β‐catenin in the center region [6](#feb212180-bib-0006){ref-type="ref"}, [7](#feb212180-bib-0007){ref-type="ref"}. In the canonical Wnt pathway, Axin1 is a component of the β‐catenin destruction complex that negatively controls Wnt signaling. Axin1 down‐regulates the amount of cytoplasmic β‐catenin, to function as a tumor suppressor gene, and several mutations of Axin1 have been identified in tumor cell lines [8](#feb212180-bib-0008){ref-type="ref"}, [9](#feb212180-bib-0009){ref-type="ref"}. In *Xenopus* development, Axin1 functions as a ventralizing gene [10](#feb212180-bib-0010){ref-type="ref"}. However, in zebrafish development, Axin1 shows dorsalizing activity in the JNK‐mediated signal pathway [11](#feb212180-bib-0011){ref-type="ref"}. Thus, Axin1 is a multifunctional gene and its function is dependent on binding partners.

WDR26 contains several protein‐interacting domains: the lis homology domain (LisH); the C‐terminal to LisH motif (CTLH) domain; and a WD40 repeat domain [12](#feb212180-bib-0012){ref-type="ref"}. A previous study suggested that WDR26 contributes to the MAPK signaling pathway [13](#feb212180-bib-0013){ref-type="ref"}. In a study of chemoattractive migration of leukocytes, WDR26 binds to the Gβ‐gamma complex and positively controls leukocyte migration [14](#feb212180-bib-0014){ref-type="ref"}, [15](#feb212180-bib-0015){ref-type="ref"}. However, there are no reports that WDR26 is associated with the Wnt signaling pathway. In the yeast *Saccharomyces cerevisiae*, nine glucose‐induced degradation‐deficient (GID) genes (*GID1--GID9*) were isolated [16](#feb212180-bib-0016){ref-type="ref"}, [17](#feb212180-bib-0017){ref-type="ref"}. The GID complex, which comprises GID1--GID9 except for GID6, acts as a polyubiquitination enzyme in yeast. Eight vertebrate homologs that share high similarities of domain architecture to yeast GID complex genes have been identified [12](#feb212180-bib-0012){ref-type="ref"}. The following are the yeast GID complex genesand their corresponding vertebrate homologs: *GID1/RanBP9*;*GID2/Rmnd5*;*GID3/UBE2H*;*GID4/C17ors39*;*GID5/ARMc8*;*GID7/WDR26*;*GID8/TWA1*; and *GID9/MAEA* [12](#feb212180-bib-0012){ref-type="ref"}. Recent studies showed that RMND5 and ARMc8 promote ubiquitination in vertebrates [18](#feb212180-bib-0018){ref-type="ref"}, [19](#feb212180-bib-0019){ref-type="ref"}, but it is still unknown whether other vertebrate homologs including WDR26 are associated with the ubiquitination pathway.

Previously, WDR26 is identified as an Axin1‐binding protein [20](#feb212180-bib-0020){ref-type="ref"}. In the present study, we found that WDR26, with Axin1, controlled β‐catenin levels to negatively regulate the expression of Wnt target genes. We also found that the binding between Axin1 and WDR26 is necessary for the ubiquitination of β‐catenin. These results reveal a function of WDR26 in the canonical Wnt signaling pathway.

Materials and methods {#feb212180-sec-0003}
=====================

Plasmid construction {#feb212180-sec-0004}
--------------------

The human and *Xenopus* WDR26 and Axin1 were amplified by RT‐PCR from cDNA templates prepared from HEK 293T cells and *Xenopus* embryos, respectively, and were subcloned into the pRK5 and modified pCS2+ vectors. Each truncated mutant was constructed by PCR and contained the following amino acid (aa) sequences. xWDR26‐1: 1--283 aa, xWDR26‐2: 1--434 aa, xWDR26‐3: 97--611 aa, xWDR26‐4: 284--611 aa, xWDR26‐5: 435--611 aa, xWDR26‐ΔLisH: 1--63 aa and 97--611 aa, xWDR26‐ΔCTLH: 1--96 aa and 182--611 aa, xWDR26‐ΔLisH‐CTLH: 1--63 aa and 182--611 aa, xAxin1‐1: 1--230 aa, xAxin1‐2: 1--450 aa, xAxin1‐3: 1--610 aa, xAxin1‐4: 231--841 aa, xAxin1‐5: 451--841 aa, xAxin1‐6: 611--841 aa. FLAG tags were fused to the N‐terminus of hWDR26 and xβ‐catenin, and C‐terminus of β‐globin, xWDR26, and its truncated constructs. MYC tags were fused to the N‐terminus of hβ‐catenin and xβ‐catenin, and C‐terminus of hAxin1. HA tag was fused to N‐terminus of ubiquitin.

Embryo handling and morpholino oligonucleotides {#feb212180-sec-0005}
-----------------------------------------------

Capped mRNA were synthesized from linearized vectors using SP6 (Roche, Basel, Switzerland) and T7 (Toyobo, Osaka, Japan) RNA polymerase. The morpholino oligonucleotides (MO) (Gene Tools, LLC, Philomath, OR, USA) used here were previously reported [21](#feb212180-bib-0021){ref-type="ref"}, [22](#feb212180-bib-0022){ref-type="ref"} and are as follows: 5′‐CGCTGCCCCGTTAGCCTGCATGTTA‐3′ (*xWDR26*‐MO). The specificity of each MO was confirmed by its ability to inhibit the translation of FLAG‐tagged mRNA containing the targeted site with or without five‐mismatched sequences. MO (10 ng) and FLAG‐tagged mRNA (100 pg) were coinjected with β‐globin‐FLAG mRNA (100 pg) as a loading control into the animal poles of four‐cell stage embryos, and the injected animal caps were dissected at stage 10. Lysates from the animal caps were subjected to western blotting with an anti‐FLAG antibody (M2, Sigma, St. Louis, MO, USA).

Morpholino oligonucleotides, mRNA, and plasmids were injected into two animal dorsal blastomeres at the eight‐cell stage for observation of embryo phenotypes and RT‐PCR analysis, into four animal blastomeres for western blot analysis, or into two ventral blastomeres at the four‐cell stage for RT‐PCR analysis. The cytoplasmic and nuclear fractions were prepared as described with modifications [23](#feb212180-bib-0023){ref-type="ref"}. Quantitative RT‐PCR analysis: Total RNA was prepared using TRIzol (Invitrogen, Carlsbad, CA, USA) from the injected region at the gastrula or neurula stage. cDNA synthesis was carried out using Moloney murine leukemia virus reverse transcriptase (Invitrogen). The sequences of the primer pairs were previously reported [24](#feb212180-bib-0024){ref-type="ref"}, [25](#feb212180-bib-0025){ref-type="ref"}, [26](#feb212180-bib-0026){ref-type="ref"} and as follows: *xWDR26*: Forward 5′‐ATGGCAACCTGCTTGACTCC‐3′; Reverse 5′‐ACAGTACCGTCGTCAGAAGC‐3′. *hWDR26*: Forward 5′‐CCGGAACTCGCCTGCTTGTC‐3′; Reverse 5′‐TGACATCCTCATCTGACTGG‐3′. *Xnr3*: Forward 5′‐CTTCTGCACTAGATTCTG‐3′; Reverse 5′‐CAGCTTCTGGCCAAGACT‐3′. *Xtwn*: Forward 5′‐AACCCAAGAAGGCGACACTATC‐3′; Reverse 5′‐GTGCCGATGGTAGGAAATGATC‐3′. *Xenopus* embryonic ornithine decarboxylase *(xODC)* was used for normalization of cDNA samples.

Whole‐mount *in situ* hybridization {#feb212180-sec-0006}
-----------------------------------

Whole‐mount *in situ* hybridization was performed as previously described [27](#feb212180-bib-0027){ref-type="ref"}. A cDNA fragment of *xWDR26* (nucleotides 709--1836; GenBank Accession No. [LC066599](LC066599)) was subcloned into pBluescriot vectors, and used as templates to generate the digoxigenin‐labeled antisense and sense RNA probes.

Antibodies, siRNA, and cell lines {#feb212180-sec-0007}
---------------------------------

The antibodies used here were previously reported [22](#feb212180-bib-0022){ref-type="ref"}, [24](#feb212180-bib-0024){ref-type="ref"} and as follows: Peroxidase conjugated anti‐GAPDH (G9295; Wako, Osaka, Japan), horseradish peroxidase‐conjugated anti‐rat IgG (GE, Little Chalfont, UK), anti‐T7 (PM022, MBL, Nagoya, Japan), anti‐HA (3F10, Roche), anti‐WDR26 (NBP1‐78041, Acris Antibodies, Herford, Germany), anti‐β‐catenin (ab32572, Abcam, Cambridge, UK) and anti‐Axin1 (C76H11, Cell Signaling, Danvers, MA, USA). The target sequences of siRNA against human *WDR26* were 5′‐TACCAAATTCCGAAATCATGTCA‐3′ (*si‐hWDR26‐1*), 5′‐GGCCGATTAGCTTTGTTAAATGT‐3′ (*si‐hWDR26‐2*), and 5′‐ATCCTATTATGTCTTTTACTATT‐3′ (*si‐hWDR26‐3*). Four‐day Wnt‐3A conditioned medium from L‐Wnt‐3A cells was used for Wnt stimulation of cultured cells. We used the following cell lines: HEK 293T cells, L cells, and L Wnt3A cells. The growth medium for each cell type is described in the American Type Culture Collection [22](#feb212180-bib-0022){ref-type="ref"}. Three‐day Wnt‐3A‐conditioned medium from L‐Wnt‐3A cells was used for Wnt stimulation of cultured cells. For western blotting analysis, at least three independent experiments were performed, and representative data were shown in figures.

Results {#feb212180-sec-0008}
=======

Interaction between WDR26 and Axin1 {#feb212180-sec-0009}
-----------------------------------

To identify novel proteins that bind to human Axin1 (hAxin1), we previously performed a high‐throughput analysis of proteins that coimmunoprecipitated with hAxin1 in HEK 293 cells using direct nanoflow liquid chromatography‐coupled tandem mass spectrometry [20](#feb212180-bib-0020){ref-type="ref"}. We identified human WDR26 (hWDR26) as a candidate protein that binds to hAxin1. The interaction of ectopically expressed hWDR26 with hAxin1 was confirmed in HEK 293T cells (Fig. [1](#feb212180-fig-0001){ref-type="fig"}A). The endogenous interaction of hWDR26 and hAxin1 was also confirmed in HEK 293T cells (Fig. [1](#feb212180-fig-0001){ref-type="fig"}B). Amino acid sequences of both WDR26 and Axin1 are well conserved between vertebrate homologs, and an interaction between ectopically expressed *Xenopus* WDR26 (xWDR26) with *Xenopus* Axin1 (xAxin1) was also confirmed in HEK 293T cells (Fig. [1](#feb212180-fig-0001){ref-type="fig"}C). To determine the region in xWDR26 responsible for binding to xAxin1, several truncated mutants of xWDR26 were examined using coimmunoprecipitation assays. We found that the N‐terminal region including LisH domain was responsible for binding to xAxin1 (Fig. [1](#feb212180-fig-0001){ref-type="fig"}D). Conversely, xWDR26 bound to xAxin1 at the central region including GSK3β‐binding domain (Fig. [1](#feb212180-fig-0001){ref-type="fig"}E).

![Interaction between WDR26 and Axin1. (A) Interaction between ectopically expressed hWDR26 and hAxin1 in HEK 293T cells. Relative intensity of each western blot was measured by [imagej]{.smallcaps}. The ratios of IP/Input of hAxin1 were calculated. Their statistical significances were determined by Mann--Whitney *U* test. *P* \< 0.01 (between lane 3/lane 1 and lane 4/lane 2). (B) Interaction between endogenous hWDR26 and hAxin1 in HEK 293T cells. Cells were treated with 10 μ[m]{.smallcaps} MG‐132 for 24 h to improve the detection. The endogenous interaction between hWDR26 and hAxin1was not detected with an anti‐WDR26 antibody (data not shown). (C) Interaction between ectopically expressed xWDR26 and xAxin1 in HEK 293T cells. Relative intensity of each western blot was measured by [imagej]{.smallcaps}. The ratios of IP/Input of xWDR26 were calculated. Their statistical significances were determined by Mann--Whitney *U* test. *P* \< 0.001 (between lane 3/lane 1 and lane 4/lane 2). (D) Interactions among ectopically expressed xAxin1 and truncated xWDR26 constructs. WDR26 protein‐interacting domains are labeled as follows: L: LisH (lis homology domain); C: CTLH (C‐terminal to LisH motif) domain; W: WD40 repeat domain. Asterisks indicate higher molecular weight bands. Constructs were transfected into HEK 293T cells. Relative intensity of each western blot was measured by [imagej]{.smallcaps}. The ratios of IP/Input of xWDR26 constructs were calculated. Their statistical significances were determined by Mann--Whitney *U* test. *P* \> 0.5 (between lane 7/lane 2 and lane 8/lane 3). *P* \> 0.1 (between lane 7/lane 2 and lane 9/lane 4). *P* \< 0.001 (between lane 7/lane 2 and lane 10/lane 5). (E) Interactions among ectopically expressed xWDR26 and truncated xAxin1 constructs. Axin1 protein‐interacting domains are labeled as follows: R: RGS (regulation of G‐protein signaling) domain; G: GSK3‐β binding domain; β: β‐catenin binding domain; D: DIX (Dishevelled and axin) domain. Constructs were transfected into HEK 293T cells. Relative intensity of each western blot was measured by [imagej]{.smallcaps}. The ratios of IP/Input of xAxin1 were calculated. Their statistical significances were determined by Mann--Whitney *U* test. *P* \< 0.01 (between lane 10/lane 2 and lane 11/lane 3). *P* \> 0.5 (between lane 10/lane 2 and lane 12/lane 4). *P* \> 0.05 (between lane 10/lane 2 and lane 13/lane 5). *P* \> 0.1 (between lane 10/lane 2 and lane 14/lane 6). *P* \< 0.01 (between lane 10/lane 2 and lane 15/lane 7). *P* \< 0.01 (between lane 10/lane 2 and lane 16/lane 8).](FEB2-590-1291-g001){#feb212180-fig-0001}

Expression patterns of *xWDR26* during Xenopus embryogenesis {#feb212180-sec-0010}
------------------------------------------------------------

To assess the possible function of xWDR26 in *Xenopus* embryonic development, we first examined the temporal and spatial expression patterns of *xWDR26* by RT‐PCR analysis and whole‐mount *in situ* hybridization (Fig. [2](#feb212180-fig-0002){ref-type="fig"}A,B--I). We found that the expression of *xWDR26* remained at a relatively constant level until stage 15, and tended to decrease slightly after stage 18 (Fig. [2](#feb212180-fig-0002){ref-type="fig"}A). Whole‐mount *in situ* hybridization revealed that *xWDR26* was expressed broadly until the gastrula stage (data not shown). Expression of *xWDR26* was gradually localized to the neural region from the late gastrula (Fig. [2](#feb212180-fig-0002){ref-type="fig"}B) to the early neurula stage (Fig. [2](#feb212180-fig-0002){ref-type="fig"}C). In the late neurula and tadpole stages, *xWDR26* was strongly expressed in the anterior neural region (Fig. [2](#feb212180-fig-0002){ref-type="fig"}D,E). These results suggest that xWDR26 might be involved in anterior formation in *Xenopus* embryos.

![Expression of xWDR26 during *Xenopus* embryogenesis. (A) Quantitative RT‐PCR revealed temporal expression of *xWDR26*. Numbers under lanes indicate developmental stages; U, unfertilized eggs. The value obtained for *xWDR26* was normalized to the level of *xODC (ornithine decarboxylase)*. The value of unfertilized eggs was set to 100 and other values were computed. Error bars represent standard deviation of the mean in three experiments. Statistical significances of *xWDR26*/*xODC* between unfertilized eggs and other stages were determined by Mann--Whitney *U* test. *P* \> 0.05 (until stage 15, and stage 26), *P* \< 0.01 (after stage 18, except for stage 26). (B--I) Whole‐mount *in situ* hybridization. (B--E) Anti‐sense RNA probe of *xWDR26* cDNA fragment was used. (F--I) Sense RNA probe of *xWDR26* cDNA fragment was used. (B and C). Expression of *xWDR26* gradually localizes to anterior neural region (B, stage 12; C, stage 15). (D and F) *xWDR26* is strongly expressed in the anterior neural region (D, stage 25; E, stage 30).](FEB2-590-1291-g002){#feb212180-fig-0002}

WDR26 is involved in the canonical Wnt pathway {#feb212180-sec-0011}
----------------------------------------------

To determine whether WDR26 is involved in the canonical Wnt pathway, we investigated the effects of knockdown of WDR26 on canonical Wnt activity. We first validated antisense morpholino oligonucleotides for *xWDR26* (*xWDR26*‐MO) in *Xenopus* embryonic cells and siRNA for *hWDR26* in cultured cells (Fig. [3](#feb212180-fig-0003){ref-type="fig"}). Although *xWDR26*‐MO inhibited the translation of FLAG‐tagged mRNA containing the targeted site, the translation of FLAG‐tagged mRNA containing five‐mismatched sequences at the targeted site was not inhibited by *xWDR26*‐MO (Fig. [3](#feb212180-fig-0003){ref-type="fig"}A). This result suggest *xWDR26*‐MO could be targeted to knockdown specifically xWDR26. The transfection of each *si‐hWDR26* RNA reduced *hWDR26* mRNA expression (Fig. [3](#feb212180-fig-0003){ref-type="fig"}B). Since the knockdown by *si‐WDR26‐3* RNA was slightly effective rather than other siRNA, we used *si‐WDR26‐3* RNA for the following experiments. A reduction in Wnt activity in the anterior region is necessary for head formation in *Xenopus* development [28](#feb212180-bib-0028){ref-type="ref"}, [29](#feb212180-bib-0029){ref-type="ref"}. The injection of *xWDR26*‐MO into dorso‐animal blastomeres of eight‐cell embryos reduced both head formation at the tadpole stage (Fig. [4](#feb212180-fig-0004){ref-type="fig"}A) and the expression of several neural marker genes at the neural stage (Fig. [4](#feb212180-fig-0004){ref-type="fig"}B, lane 1 and lane 2). The injection of xWDR26 plasmids containing the MO‐targeted site with five‐mismatched sequences slightly increased the expression of several neural marker genes, except for xRX‐1 (Fig. [4](#feb212180-fig-0004){ref-type="fig"}B, lane 1 and lane 3). These reductions of head formation and neural marker gene expression by the knockdown of xWDR26 were partially rescued by coinjection of xWDR26 plasmids (Fig. [4](#feb212180-fig-0004){ref-type="fig"}A, B, lane 2 and lane 4). When *Xwnt‐8* mRNA is injected into the ventral sides of four‐cell embryos, the target genes of Wnt signaling are induced (Fig. [4](#feb212180-fig-0004){ref-type="fig"}C, lane 2 and lane3). Ventral injection of *xWDR26*‐MO tended to increase the expression of Wnt target genes that were induced by coinjection of *Xwnt‐8* mRNA (Fig. [4](#feb212180-fig-0004){ref-type="fig"}C, lane 3 and lane 4). Coinjection of *xWDR26* mRNA containing the MO‐targeted site with five‐mismatched sequences tended to be restituted with the increasing of Wnt target genes by *xWDR26*‐MO (Fig. [4](#feb212180-fig-0004){ref-type="fig"}C, lane 5 and lane 6). The coinjection of *hWDR26* mRNA showed similar results to the coinjection of *xWDR26* (Fig. [4](#feb212180-fig-0004){ref-type="fig"}D). The knockdown of *hWDR26* by siRNA in cultured cells did not affect the expression of a Wnt target gene, Axin2, in the 'Wnt off' state (Fig. [4](#feb212180-fig-0004){ref-type="fig"}E, lane 1 and lane 2). This suggests that small amounts of WDR26 are enough to keep the 'Wnt off' state in the canonical Wnt signaling pathway. However, the exression of *Axin2* was increased in the 'Wnt on' state (Fig. [4](#feb212180-fig-0004){ref-type="fig"}E, lane 3 and lane 4). These results suggest that WDR26 contributes to the negative regulation of the canonical Wnt signaling pathway in the 'Wnt on' state.

![The specificity of antisense morpholino oligonucleotides for xWDR26 and siRNA for *hWDR26*. (A) Western blotting analysis of injected embryos at stage 10. *xWDR26*‐MO inhibited the translation of FLAG‐tagged mRNA containing the targeted site. The translation of FLAG‐tagged mRNA containing five‐mismatched sequences at the targeted site was not inhibited by *xWDR26*‐MO. β‐globin is used as loading control. (B) Quantitative RT‐PCR analysis. Three siRNA against *hWDR26* were transfected into HEK 293T cells. *GAPDH* was used as a loading control. The value obtained for each *si‐hWDR26* RNA was normalized to the level of *GAPDH*. The value of transfection of *si‐Control* RNA (lane 1) was set to 100 and other values were computed. Error bars represent standard deviation of the mean in three experiments. Statistical significances of *hWDR26*/*hGAPDH* between *si‐Control* RNA transfection and *si‐hWDR26* RNA transfection were determined by Mann--Whitney *U* test. *P* \< 0.01 (between lane 1 and each other lane).](FEB2-590-1291-g003){#feb212180-fig-0003}

![WDR26 is involved in the canonical Wnt pathway. (A) Phenotypes of *xWDR26*‐MO injected embryos. Control‐MO (40 ng) or *xWDR26*‐MO (40 ng) was coinjected with or without 5‐mis‐*xWDR26* plasmids (20 pg) into two dorsal animal blastomeres of eight‐cell embryos. Phenotypes are categorized into normal, mild (small eyes), or severe (no eye). The injection of 5‐mis‐*xWDR26* plasmids had no effect on head formation. Coinjection of 5‐mis‐*xWDR26* plasmids with *xWDR26*‐MO rescued the phenotypes of the *xWDR26*‐morphants. The ratio of each phenotype in the injected embryos was indicated in the graph. Lane 1: *n* = 21, normal (100%). Lane 2: *n* = 45, normal (8.9%), mild (35.5%), severe (55.6%). Lane 3: *n* = 16, normal (81.3%), mild (18.7%). Lane 4: *n* = 14, normal (50.0%), mild (21.4%), severe (28.4%). (B--E) Quantitative RT‐PCR analysis. The value obtained for each marker gene or Wnt target gene was normalized to the level of *xODC* or *hGAPDH*. The value of control (lane 1) was set to 100, and other values were computed (other lanes). Error bars represent standard deviation of the mean in three experiments. Statistical significances of values among indicated lanes were determined by Mann--Whitney *U* test. (B) Quantitative RT‐PCR analysis of anterior neural marker genes, *xNCAM*,*xOTX‐2*,*xPAX‐6*,*xSIX‐3*,*xRX‐1* in the head region of each molpholino‐ or plasmid‐injected embryo at stage 28. The injection was performed with similar methods indicated in (A). The value of *neural marker gene*/*xODC* of Control‐MO injected embryos (lane 1) was set to 100 and other values were computed. *P* \< 0.01: all neural marker genes (between lane 1 and lane 2). *P* \< 0.01: neural marker genes except for xRX‐1, *P* \> 0.1: xRX‐1 (between lane 1 and lane 3). *P* \< 0.01: all neural marker genes (between lane 2 and lane 4). (C) Quantitative RT‐PCR analysis of early dorsal Wnt target genes (*Xtwn*,*Siamois*,*Xnr3*) at stage 10. Control‐MO (40 ng), *xWDR26*‐MO (40 ng), and *Xwnt‐8* (0.5 pg) mRNA were ventrally coinjected with *xWDR26* mRNA (500 pg). The value of *Wnt target gene*/*xODC* of dorsal sectors (lane 1) was set to 100, and other values were computed. The value of uninjected ventral sectors was used as negative control. *P* \< 0.005: all Wnt target genes (between lane 2 and lane 3). *P* \< 0.005: *Xnr3* and *Siamois*,*P* \> 0.1: *Xtwn* (between lane 3 and lane 4). *P* \< 0.05: all Wnt target genes (between lane 3 and lane 5). *P* \< 0.005: Siamois and Xtwn, *P* \> 0.05: Xnr3 (between lane 5 and lane 6). (D) Quantitative RT‐PCR analysis of early dorsal Wnt target genes (*Xtwn*,*Siamois*,*Xnr3*). Control‐MO (40 ng), *xWDR26*‐MO (40 ng) and *Xwnt‐8* (0.5 pg) mRNA were ventrally coinjected with *hWDR26* mRNA (500 pg). The value of *Wnt target gene*/*xODC* of ventral sectors (lane1) of Control‐MO injected embryos was set to 100, and other values were computed. *P* \< 0.005: all Wnt target genes (between lane 1 and lane 2). *P* \< 0.005: all Wnt target genes (between lane 1 and lane 3). *P* \< 0.005: all Wnt target genes (between lane 2 and lane 4). (E) Quantitative RT‐PCR analysis of *hAxin2* in HEK 293T cells. The *siRNA*‐transfected cultured cells were stimulated with Wnt3A conditioned medium from L‐Wnt‐3A cells for 6 h. The conditioned medium from L cells was used for unstimulated control. The value of *hAxin2*/*hGAPDH* of unstimulated control (lane1) was set to 100, and other values were computed. *P* \> 0.1 (between lane 1 and lane 2). *P* \< 0.005 (between lane 1 and lane 3). *P* \< 0.005 (between lane 3 and lane 4).](FEB2-590-1291-g004){#feb212180-fig-0004}

WDR26 affects on the stability of β‐catenin {#feb212180-sec-0012}
-------------------------------------------

The homolog of WDR26 in yeast, GID7, is a component of the GID complex that mediates polyubiquitination of proteins [16](#feb212180-bib-0016){ref-type="ref"}. An increase in β‐catenin protein in the cytoplasm is essential for canonical Wnt signaling [2](#feb212180-bib-0002){ref-type="ref"}. We investigated whether WDR26 controls the amount of β‐catenin protein. The expression of either human or *Xenopus* WDR26 reduced the amount of β‐catenin protein in cultured cells in a dose‐dependent manner (Fig. [5](#feb212180-fig-0005){ref-type="fig"}A,B). The reduction of endogenous xβ‐catenin protein in the cytoplasmic fraction was observed in *xWDR26 mRNA*‐injected *Xenopus* embryonic cells (Fig. [5](#feb212180-fig-0005){ref-type="fig"}C). The injection of *hWDR26* mRNA into *Xenopus* embryonic cells also reduced the amount of endogenous xβ‐catenin protein in the cytoplasmic fraction (Fig. [5](#feb212180-fig-0005){ref-type="fig"}D). The knockdown of *hWDR26* by siRNA did not affect on the amount of endogenous hβ‐catenin protein in cultured cells (Fig. [5](#feb212180-fig-0005){ref-type="fig"}E, lane 1 and lane 2). However, the amount of endogenous hβ‐catenin protein was increased by the knockdown of *hWDR26* in Wnt‐stimulated cells (Fig. [5](#feb212180-fig-0005){ref-type="fig"}E, lane 3 and lane 4). Moreover, in *Xenopus*, the endogenous xβ‐catenin protein tended to be up‐regulated by the knockdown of xWDR26 (Fig. [5](#feb212180-fig-0005){ref-type="fig"}F). We also confirmed that both knockdown and overexpression of WDR26 did not affect to the expression of β‐catenin mRNA (Fig. S1A, B). Moreover, we investigated β‐catenin stability by the cycloheximide chase assay. In results, the transfection of xWDR26 slightly promoted the degradation of β‐catenin (Fig. [5](#feb212180-fig-0005){ref-type="fig"}G). These results suggest that WDR26 controls β‐catenin protein stability in the canonical Wnt signaling pathway.

![Effects of WDR26 to the stability of β‐catenin. (A--B) Western blotting analysis of ectopically expressed β‐catenin in HEK 293T cells. The amounts of transfected plasmids (*hWDR26* and *xWDR26*) were indicated (0, 0.5, 1.5, 5 μg per dish). GAPDH was used as a loading control. (C--D) Western blotting analysis of endogenous xβ‐catenin in *Xenopus* embryonic cells. The amounts of injected mRNA (*xWDR26* and *hWDR26*) were indicated (0, 250, 1000 pg per embryo). Cytoplasmic fractions of lysates extracted at the gastrula stage were used here. (E) Western blotting analysis of endogenous hβ‐catenin in HEK 293T cells. *si‐hWDR26‐3*, an siRNA against *hWDR26,* was transfected into HEK 293T cells. Twenty‐four hours after transfection, cells were stimulated with Wnt3A for 6 h. Relative intensity of each western blot (upper panel) was measured by [imagej]{.smallcaps}. The ratios of IP/Input of hβ‐catenin/hGAPDH were calculated and graphed. The value obtained for each hβ‐catenin signal was normalized to the level of hGAPDH signal. The value of unstimulated control (lane 1) was set to 100, and other values were computed (other lanes). Error bars represent standard deviation of the mean in three experiments. Statistical significances of values among indicated lanes were determined by Mann--Whitney *U* test. *P* \> 0.1 (between lane 1 and lane 2). *P* \< 0.005 (between lane 1 and lane 3). *P* \< 0.005 (between lane 3 and lane 4). (F) Western blotting analysis of endogenous xβ‐catenin in *Xenopus* embryonic cells. *xWDR26*‐MO (40 ng) was injected into animal blastomeres of eight‐cell embryos, and lysates were extracted at the gastrula stage. *x*β*‐catenin*‐MO was used as a positive control. Relative intensity of each western blot (upper panel) was measured by [imagej]{.smallcaps}. The ratios of IP/Input of xβ‐catenin/xGAPDH were calculated and graphed (bottom panel). The value for Control‐MO‐injected embryos (lane 1) was set to 100, and other values were computed (other lanes). Error bars represent standard deviation of the mean in three experiments. Statistical significances of values among indicated lanes were determined by Mann--Whitney *U* test. *P* \< 0.01 (between lane 1 and lane 2). *P* \< 0.01 (between lane 1 and lane 3). (G) Western blotting analysis of the stability of β‐catenin in HEK 293T cells. xWDR26 was transfected at 24 h after transfection of xβ‐catenin. Five hours after the transfection xWDR26, cells were stimulated with cycloheximide (CHX) (20 mg·mL^−1^) during indicated hours. We measured relative intensity of each western blot (upper panel) by [imagej]{.smallcaps}, calculated the ratios of β‐catenin/GAPDH, and graphed (bottom panel). The value for cells untreated with cyclohexmide was set to 100, and other values were computed (other lanes). Solid line indicates ratios of β‐catenin/GAPDH (left panels) as control. Dotted line indicates ratios of β‐catenin/GAPDH with xWDR26 transfection (right panels).](FEB2-590-1291-g005){#feb212180-fig-0005}

Possible mechanisms of β‐catenin degradation by WDR26 {#feb212180-sec-0013}
-----------------------------------------------------

We found that hWDR26 did not bind to hβ‐catenin (Fig. [6](#feb212180-fig-0006){ref-type="fig"}A) although hAxin1 binds to both hWDR26 and hβ‐catenin (Figs [1](#feb212180-fig-0001){ref-type="fig"} and [6](#feb212180-fig-0006){ref-type="fig"}A and ref. [6](#feb212180-bib-0006){ref-type="ref"}). This suggests that WDR26 controls the stability of β‐catenin through binding with Axin1. To examine the binding site of WDR26 with Axin1 in detail, we made deletion constructs of xWDR26, removing either the LisH domain, the CTLH domain, or both domains (see Fig. [6](#feb212180-fig-0006){ref-type="fig"}B, upper). The CTLH domain‐deleted construct bound to xAxin1, but the LisH domain‐deleted and the LisH‐CTLH domain‐deleted constructs did not bind (Fig. [6](#feb212180-fig-0006){ref-type="fig"}B). The expression of Wnt target genes induced by ventral injection with *Xwnt‐8* mRNA was decreased by coinjection with *xWDR26* mRNA, but not by mRNA of the LisH domain‐deleted construct (Fig. [6](#feb212180-fig-0006){ref-type="fig"}C). Moreover, the expression of the LisH domain‐deleted WDR26 construct hardly reduces the amount of xβ‐catenin protein (Fig. [6](#feb212180-fig-0006){ref-type="fig"}D), suggesting that binding between WDR26 and Axin is necessary for β‐catenin degradation. To confirm that WDR26 contributes to the ubiquitination of β‐catenin, we investigated whether the ubiquitination of β‐catenin is altered in the presence of the proteasome inhibitor, MG‐132. First, we confirmed the ubiquitination of xβ‐catenin without the MG‐132 treatment. Although the ubiquitination of xβ‐catenin was not increased by transfection of xWDR26 or xAxin1, both transfection of xWDR26 and xAxin1 slightly increased the ubiquitination of xβ‐catenin (Figs [6](#feb212180-fig-0006){ref-type="fig"}E and S2, lane 1 to lane 4). This suggests that the ubiquitinated xβ‐catenin could be immediately degraded via the ubiquitin proteasome pathway in the 'Wnt off' state. Under the MG‐132 treatments, the ubiquitination of xβ‐catenin was only slightly increased by cotransfection of xAxin1 alone, but the cotransfection of both xWDR26 and xAxin1 highly increased the ubiquitination of xβ‐catenin (Figs [6](#feb212180-fig-0006){ref-type="fig"}F and S2, lane 5 to lane 8). We considered that the amount of β‐catenin was reduced during 24 h before the treatments with MG‐132 (see figure legends). These results suggest that WDR26 regulates the ubiquitination of β‐catenin for its degradation, and that binding of WDR26 and Axin is important for this ubiquitination.

![Interaction between WDR26 and Axon1 is critical for β‐catenin degradation. (A) Interaction between ectopically expressed hWDR26 and hβ‐catenin in HEK 293T cells. As a positive control, the binding between hAxin1 and hβ‐catenin was observed. (B) Interactions among ectopically expressed xAxin1 and truncated xWDR26 constructs. A schematic of xWDR26 and truncated constructs is indicated in the upper side. Asterisks indicate original size of each construct, and several bands of high molecular weight were observed. (C) Quantitative RT‐PCR analysis of early dorsal Wnt target genes (*Xtwn*,*Siamois*,*Xnr3*). *xWDR26* or *xWDR26‐deltaLisH* mRNA (500 pg) and *Xwnt‐8* (0.5 pg) mRNA were ventrally coinjected. The value obtained for each Wnt target gene was normalized to the level of *xODC*. The value of *Wnt target gene*/*xODC* of only *Xwnt‐8*‐injected embryos (lane 1) was set to 100, and other values were computed. Statistical significances of values among indicated lanes were determined by Mann--Whitney *U* test. *P* \< 0.01: all Wnt target genes (between lane 1 and lane 2). *P* \> 0.1: all Wnt target genes (between lane 1 and lane 3). *P* \< 0.01: all Wnt target genes (between lane 2 and lane 3). (D) Western blotting analysis of ectopically expressed β‐catenin in HEK 293T cells. The amounts of transfected plasmid, *xWDR26‐deltaLisH,* were gradually increased (0, 0.5, 1.5, 5 μg per dish). (E and F) Western blotting analysis of ubiquitinated xβ‐catenin in HEK 293T cells. At 24 h after transfection, cells were untreated (E) or treated with 10 μ[m]{.smallcaps} MG‐132 for 24 h (F). The HA‐Ubiquitin was cotransfected to detect ubiquitinated xβ‐catenin.](FEB2-590-1291-g006){#feb212180-fig-0006}

GSK‐3β plays a key role in the β‐catenin degradation, and xWDR26 bound to xAxin1 at the central region including GSK3β‐binding domain (Fig. [1](#feb212180-fig-0001){ref-type="fig"}E). Therefore, we investigated whether GSK‐3β affects on the function of WDR26 and the binding between WDR26 and Axin. The lithium chloride and SB216763 are GSK‐3β inhibitors, and increased the stability of β‐catenin (Fig. [7](#feb212180-fig-0007){ref-type="fig"}A, B, lane 1 and lane 3). However xWDR26 reduced the stability of β‐catenin under these treatments (Fig. [7](#feb212180-fig-0007){ref-type="fig"}A,B, lane 3 and lane 4). This suggests that the function of xGSK‐3β would be not related with the WDR26 function for the β‐catenin stability. Also, xGSK‐3β did not increase and decrease the association between xWDR26 and xAxin1 (Fig. [7](#feb212180-fig-0007){ref-type="fig"}C). These suggest that the mechanisms of degradation of β‐catenin by WDR26 would be independent from the canonical degradation mechanisms by the APC/Axin/GSK‐3β complex.

![Effects of GSK‐3β on WDR26 function. (A and B) Western blotting analysis of ectopically expressed β‐catenin in HEK 293T cells with or without lithium chloride treatments (A) and SB216763 treatments (B). GAPDH was used as a loading control. (C) Interaction between ectopically expressed xWDR26 and xAxin1 in HEK 293T cells with or without cotransfection of GSK‐3β. The amounts of transfected plasmids (*GSK‐3*β) were indicated (0, 0.5, 1.5, 5 μg per dish). GAPDH was used as a loading control. Relative intensity of each western blot was measured by [imagej]{.smallcaps}. The ratios of IP/Input of xWDR26 were calculated. Their statistical significances were determined by Mann--Whitney *U* test. *P* \> 0.1 (between lane 7/lane 2 and lane 8/lane 3). *P* \> 0.1 (between lane 7/lane 2 and lane 9/lane 4). *P* \> 0.1 (between lane 7/lane 2 and lane 10/lane 5).](FEB2-590-1291-g007){#feb212180-fig-0007}

Discussion {#feb212180-sec-0014}
==========

In this study, we showed WDR26 is important for degradation of β‐catenin in the canonical Wnt signaling pathway. In *Xenopus* development, the inactivation of the Wnt signal by antagonists such as DKK‐1 and Cerberus is necessary for head formation [28](#feb212180-bib-0028){ref-type="ref"}, [30](#feb212180-bib-0030){ref-type="ref"}. Expression of *xWDR26* is strongly localized to the anterior neural region after the neurula stage (Fig. [2](#feb212180-fig-0002){ref-type="fig"}D,E). Additionally, knockdown of xWDR26 in the anterior ectodermal region inhibited head formation, including eyes and marker genes (Fig. [4](#feb212180-fig-0004){ref-type="fig"}A,B). Moreover, Wnt target genes were increased by the knockdown of xWDR26 (Fig. [4](#feb212180-fig-0004){ref-type="fig"}D). These suggest that WDR26 acts as a negative regulator of Wnt signaling during embryogenesis.

The degradation of β‐catenin is regulated by the complex of Axin, APC, and GSK‐3β in the 'Wnt off' state. The amount of β‐catenin protein was reduced by the expression of WDR26 (Fig. [5](#feb212180-fig-0005){ref-type="fig"}A,B), although we did not confirm direct binding of WDR26 to β‐catenin (Fig. [6](#feb212180-fig-0006){ref-type="fig"}A). Interestingly, the deleted construct of xWDR26 that did not bind to xAxin1, did not reduce significantly either the expression of Wnt target genes or β‐catenin levels (Fig. [6](#feb212180-fig-0006){ref-type="fig"}C,D). Moreover, the coexpression of Axin1 and WDR26 increased the ubiquitination of β‐catenin (Fig. [6](#feb212180-fig-0006){ref-type="fig"}E). These results suggest that the degradation of β‐catenin by WDR26 requires binding between WDR26 and Axin1, and WDR26 is a component of the β‐catenin degradation complex. Axin1 was also expressed in the anterior neural region in *Xenopus* embryos (data not shown and ref. [31](#feb212180-bib-0031){ref-type="ref"}), suggesting that WDR26 and Axin1 regulate anterior formation through their inhibitory effects in *Xenopus* development. A recent report indicated that oxidative stress induces apoptosis and regulates the expression of WDR26 in cardiomyocytes. Moreover, the expression of WDR26 inhibits apoptosis induced by oxidative stress [32](#feb212180-bib-0032){ref-type="ref"}. However, overexpression and activation of β‐catenin induces apoptosis during carcinogenesis and development [33](#feb212180-bib-0033){ref-type="ref"}, [34](#feb212180-bib-0034){ref-type="ref"}, [35](#feb212180-bib-0035){ref-type="ref"}. In melanoma cells, Axin1 acts as a mediator of apoptosis with β‐catenin activation and BRAF inhibition [36](#feb212180-bib-0036){ref-type="ref"}. Taken together, these facts suggest that WDR26 and Axin1 play coordinating roles for the inhibitory effects through the degradation of β‐catenin in Wnt signaling pathway.

Vertebrate β‐catenin has 26 lysine residues, and each lysine position is well conserved. Recent studies indicated the presence of several ubiquitination pathways of β‐catenin. β‐TrCP ubiquitinates on lysine 19 and 49 of β‐catenin in a phosphorylation‐dependent manner, while Siah‐1 ubiquitinates β‐catenin on lysine 660 and 671 in the p53‐dependent pathway [37](#feb212180-bib-0037){ref-type="ref"}, [38](#feb212180-bib-0038){ref-type="ref"}. Jade‐1 ubiquitinates β‐catenin in a similar phosphorylation‐dependent manner to β‐TrCP, but the ubiquitination by Jade‐1 occurs in both 'Wnt off' and 'Wnt on' states [38](#feb212180-bib-0038){ref-type="ref"}, [39](#feb212180-bib-0039){ref-type="ref"}. However, it is known that ARMc8/GID5 and RMND5/GID2, predicted vertebrate homologs of the GID complex, contribute to the ubiquitination pathway. ARMc8 binds to α‐catenin to target it for degradation by the proteasome [18](#feb212180-bib-0018){ref-type="ref"}, and RMND5 has an E3 ubiquitin‐ligase activity and inhibits forebrain formation in *Xenopus*, like WDR26 [19](#feb212180-bib-0019){ref-type="ref"}. Therefore, it is suggested that WDR26 forms a new ubiquitination pathway of β‐catenin with vertebrate GID complex homologs. Further study will be needed to identify how WDR26 controls the ubiquitination of β‐catenin.
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**Fig. S1.** (A) Quantitative RT‐PCR analysis of *h*β*‐catenin* in HEK 293T cells. (B) Quantitative RT‐PCR analysis of *x*β*‐catenin* in *Xenopus* embryonic cells.
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Click here for additional data file.
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**Fig. S2.** Semiquantitative analysis of western blots in Fig. [6](#feb212180-fig-0006){ref-type="fig"}E,F.

###### 

Click here for additional data file.
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